Description and Brand Names
Información sobre medicamentos proporcionada por: IBM Micromedex
US Brand Name
Niraparib is used as first-line maintenance treatment in patients with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. It is also used as maintenance treatment in patients with recurrent ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. This medicine is used in patients who have had received platinum-based cancer medicines.
Niraparib is also used to treat advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer in patients who have received 3 or more cancer treatment regimens, and with tumors that are caused by a certain “BRCA” gene mutation, or a positive laboratory test, and whose cancer was in response to treatment with platinum-based cancer medicines, and who have progressed more than 6 months after the last treatment.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms: